Roche’s US subsidiary Genentech announces manufacturing expansion in the U...
Genentech, a member of the Roche Group, has announced plans to invest approximately US$750 million in a new device fill-finish manufacturing facility at its 75-acre campus in Hillsboro, Oregon. The investment will...

